Medical Devices US

US Hearing Aids (OTC) Market Analysis, 2024–2034

US Hearing Aids (OTC) Market Industry Trends and Forecast to 2034: Segmented by (Product, Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $646.3 Mn Estimated value
Estimate 2025 $708.4 Mn 40.3% of the global market
Projected 2034 $1.62 Bn 128.2% Adds $908.0 Mn over 9 forecast years
CAGR 2025–2034 9.6% Faster than 70% of 173 Medical Devices markets here
Key players 6 +1
  • US is 40.34% of the global market.
  • In North America, the largest is US (this report) at $708.4 Mn.
  • Fastest growing: Canada at 11.9% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$908.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Hearing Aids (OTC) Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $646.3 Mn — —
2025 (base) $708.4 Mn +$62.0 Mn —
2026 (forecast) $776.4 Mn +$68.0 Mn +9.6%
2027 (forecast) $850.9 Mn +$74.5 Mn +20.1%
2028 (forecast) $932.6 Mn +$81.7 Mn +31.7%
2029 (forecast) $1.02 Bn +$89.5 Mn +44.3%
2030 (forecast) $1.12 Bn +$98.1 Mn +58.1%
2031 (forecast) $1.23 Bn +$107.5 Mn +73.3%
2032 (forecast) $1.35 Bn +$117.9 Mn +90%
2033 (forecast) $1.47 Bn +$129.2 Mn +108.2%
2034 (forecast) $1.62 Bn +$141.6 Mn +128.2%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.76 Bn
  2. North America $766.4 Mn
  3. US (this report) $708.4 Mn
  4. APAC $379.3 Mn
  5. Europe $276.6 Mn
  6. Canada $157.3 Mn
  7. China $155.1 Mn
  8. Japan $107.6 Mn
  9. Latin America $78.9 Mn
  10. Middle East $76.9 Mn
  11. Germany $65.6 Mn
  12. Italy $45.9 Mn
  13. France $42.6 Mn
  14. UK $38.3 Mn
  15. Brazil $39.2 Mn
  16. Spain $36.5 Mn
  17. India $35.4 Mn
  18. Ecuador $33.3 Mn
  19. Saudi Arabia $30.7 Mn
  20. Africa $29.9 Mn
  21. Mexico $23.0 Mn
  22. Australia $19.9 Mn
  23. Russia $19.4 Mn
  24. New Zealand $17.8 Mn
  25. South Africa $10.7 Mn
  26. UAE $8.5 Mn
  27. Egypt $5.4 Mn
  28. Philippines $3.9 Mn
  29. Hong Kong $3.1 Mn
  30. Malaysia $2.7 Mn
  31. Thailand $2.1 Mn
  32. Singapore $2.0 Mn
  33. Kenya $1.2 Mn

The US Hearing Aids (OTC) Market Analysis Executive Summary

Over-the-counter hearing aids are sold directly to adults with mild to moderate hearing loss, without a prescription or fitting by a specialist.

Key segments of the hearing Aids (OTC) market include product (Behind-the-Ear, In-the-Ear and Earbud-Style) and channel (Retail Pharmacies, Online and Electronics Stores).

US Hearing Aids (OTC) Market Dynamics

Market Growth Drivers

An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the hearing Aids (OTC) market. Older adults and their families are spending more on staying active and independent.

Opportunity

Preventive care, personalised plans based on biomarkers and home-based services give the hearing Aids (OTC) market room to grow, especially in fast-ageing countries in Asia and Europe.

Market Restraints

Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the hearing Aids (OTC) market.

Competitive Landscape for Hearing Aids (OTC) Market in US

The hearing Aids (OTC) market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Hearing Aids (OTC) Market in US

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how hearing Aids (OTC) products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Hearing Aids (OTC) right now, from free public sources.

Latest research 2,604 papers since 2021 (worldwide)

  1. Patient-Reported Hearing-Aid Use Patterns and Noisy-Room Communication Difficulty While Using Hearing Aids Among U.S. Adults Aged 45 Years or Older: Analyses of the 2019 and 2024 NHIS. Patient preference and adherence, 2026
  2. Hearing assistance technologies and social health among individuals with care and support needs: a scoping review. BMC geriatrics, 2026
  3. Trends in the timing of non-implantable bone-conduction hearing rehabilitation in children with microtia or aural atresia: A 14-year retrospective study. International journal of pediatric otorhinolaryngology, 2026
  4. Effect of social frailty on patient-reported hearing aid benefits among older adults in Japan: a per-protocol cohort study. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026
  5. Neuromodulatory effects of audio-proprio-phonatory reinforcement training on subjective tinnitus, a HD-EEG study protocol. PloS one, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Hearing Aids (OTC) in context

The US compared

  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]

Questions, answered with public data

How many clinical trials on Hearing Aids (OTC) are running in the US?
4 studies are recruiting, active or about to start in the US.[4]
How much research is published on Hearing Aids (OTC)?
PubMed lists 2,604 papers added since January 2021 that match this market, worldwide.[5]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.

[5] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Hearing Aids (OTC) in US? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Bone and Joint Health: Supplements for an Ageing Population1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence… Eye Health Supplements: Screens, Ageing and Vision2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a… Collagen Supplements: Skin, Joints and Real EvidenceCollagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits…
Back to Catalogue
Keep exploring

Related Medical Devices reports in US

See all
Same topic, other categories

Related on hearing and geriatric

See the topic